HEIDI HENSON

Corporate Board Profile

Tech Score: 0/100

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2023-05-01	The Audit Committee consists of three directors: Ms. Henson (Chair), Ms. Flowers and Mr. Klosk. ... Our Compensation Committee consists of three directors: Mr. Klosk (Chair), Dr. Brown and Ms. Henson. ... The following table sets forth information on all compensation to Lisata's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2022. ... Heidi Henson $18,783 Total Compensation.
2024-04-29	Ms. Henson was appointed to the Lisata Board in September 2022 and serves as the Chairman of the Audit Committee. Ms. Henson possesses two decades of financial operations experience with both public and private companies.

Filing Date

Source Excerpt

2023-05-01

The Audit Committee consists of three directors: Ms. Henson (Chair), Ms. Flowers and Mr. Klosk. ... Our Compensation Committee consists of three directors: Mr. Klosk (Chair), Dr. Brown and Ms. Henson. ... The following table sets forth information on all compensation to Lisata's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2022. ... Heidi Henson $18,783 Total Compensation.

2024-04-29

Ms. Henson was appointed to the Lisata Board in September 2022 and serves as the Chairman of the Audit Committee. Ms. Henson possesses two decades of financial operations experience with both public and private companies.

Perspective Therapeutics, Inc.

Filing Date	Source Excerpt
2023-08-22	Heidi Henson has been a director of the Company since June 1, 2023... The current members of the Audit Committee are Ms. Henson (Chair), Mr. Williamson and Dr. Morich... The current members of the Compensation Committee are Mr. Williamson (Chair), Ms. Woods and Ms. Henson... Board Committees and Meetings... Heidi Henson: Member of Board, Chair of Audit Committee, Member of Compensation Committee... During the six-month transition period ended December 31, 2022 and the fiscal year ended June 30, 2022, each non-employee director received a cash retainer of $5,000 per month... In February 2023, the Compensation Committee approved changes to the non-employee director compensation program to provide (i) $60,000 annual cash retainer; (iii) additional annual cash retainers for committee chairs equal to $15,000...
2024-04-18	Ms. Henson holds a Bachelor of Accountancy from the University of San Diego and is a member of the Association of Bioscience Financial Officers, or ABFO. Our Board of Directors believes that Ms. Henson’s experience as a financial professional with over 25 years of experience in both public and private companies qualifies her to serve on our Board.

Filing Date

Source Excerpt

2023-08-22

Heidi Henson has been a director of the Company since June 1, 2023... The current members of the Audit Committee are Ms. Henson (Chair), Mr. Williamson and Dr. Morich... The current members of the Compensation Committee are Mr. Williamson (Chair), Ms. Woods and Ms. Henson... Board Committees and Meetings... Heidi Henson: Member of Board, Chair of Audit Committee, Member of Compensation Committee... During the six-month transition period ended December 31, 2022 and the fiscal year ended June 30, 2022, each non-employee director received a cash retainer of $5,000 per month... In February 2023, the Compensation Committee approved changes to the non-employee director compensation program to provide (i) $60,000 annual cash retainer; (iii) additional annual cash retainers for committee chairs equal to $15,000...

2024-04-18

Ms. Henson holds a Bachelor of Accountancy from the University of San Diego and is a member of the Association of Bioscience Financial Officers, or ABFO. Our Board of Directors believes that Ms. Henson’s experience as a financial professional with over 25 years of experience in both public and private companies qualifies her to serve on our Board.

Data sourced from SEC filings. Last updated: 2025-08-30